From cells to systems: A comprehensive perspective on In-Vitro, In-Vivo, and 3D culture models of heart failure
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2025.178356 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Kushal Vesmaker und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Birla Institute of Technology and Sciences (BITS) Pilani, Hyderabad Campus, Jawahar Nagar, Shameerpet, Hyderabad, Telangana, …. Hauptthemen laut MEDLINE: Heart Failure, Cell Culture Techniques, Cell Culture Techniques, Three Dimensional. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 252 Literaturangaben. Gefördert von: Chronic Disease Research Foundation, Indian Council of Medical Research.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) is a cardiovascular condition with varying etiology, in which the heart ceases to pump sufficient blood to the body. It is a major cause of death worldwide, with prevalence increasing continuously over the years. Despite tremendous progress in understanding HF pathophysiology, creating effective therapy strategies remains challenging, with high mortality rates and translating experimental findings into an effective therapeutic. Drug testing for HF utilizes in-vitro and in-vivo models to examine prospective treatments as well as therapeutic efficacy. In-vivo murine models of HF are frequently employed to recreate human disease phenotypes and identify their underlying mechanisms. It has significantly improved our understanding of the mechanisms underlying HF, paving the way for successful treatments. These models provide numerous information about cardiac functionality, but species-specific genetic differences may restrict their translational utility. In-vitro models, such as 2D cell cultures, offer a controlled environment for studying cellular responses to therapeutic interventions. However, standard 2D cultures fail to reproduce the 3D architecture and the cell-cell interaction in complex organ-level systems. Introducing 3D in-vitro models provides a physiologically realistic platform for an accurate replication of the in-vivo cardiac milieu, which is critical for accurate preclinical drug testing. Combining in-vitro and in-vivo techniques is crucial for developing HF therapeutics, as each model carries intrinsic advantages and limitations in representing the complexity of the disease. This review focuses on in-vitro and in-vivo HF models, highlighting animal models, 2D cultures, and emerging trends in 3D in-vitro models, offering potential for streamlining the drug discovery process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Birla Institute of Technology and Sciences (BITS) Pilani, Hyderabad Campus, Jawahar Nagar, Shameerpet, Hyderabad, Telangana, 500078, India.
- Department of Pharmacy, Birla Institute of Technology and Sciences (BITS) Pilani, Hyderabad Campus, Jawahar Nagar, Shameerpet, Hyderabad, Telangana, 500078, India. Electronic address: artidhar@hyderabad.bits-pilani.ac.i…
Förderung
- Chronic Disease Research Foundation
- Indian Council of Medical Research
Zitieren
APA
Vesmaker, K., Venkadakrishnan, J., & Dhar, A. (2025). From cells to systems: A comprehensive perspective on In-Vitro, In-Vivo, and 3D culture models of heart failure. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178356
Vancouver
Vesmaker K, Venkadakrishnan J, Dhar A. From cells to systems: A comprehensive perspective on In-Vitro, In-Vivo, and 3D culture models of heart failure. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178356
BibTeX
@article{Vesmaker2025,
author = {Vesmaker, Kushal and Venkadakrishnan, Jegadheeswari and Dhar, Arti},
title = {From cells to systems: A comprehensive perspective on In-Vitro, In-Vivo, and 3D culture models of heart failure},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2025.178356}
}
EUVIMED